Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benefits of Insulin Supplementation for Hyperglycemia in Hospitalized Type 2 Diabetes
NCT02408120Phase 4Completed
- Sponsor
- Emory University
- Start
- Oct 2015
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Emory University. Started Oct 2015; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02408120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408120.